Quarterly Earnings Forecast Review: Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharma

Truenorth Decreased Regeneron Pharmaceuticals (REGN) Holding by $304911; Horizon Investments Continues to

Contravisory Investment Management Inc who had been investing in Disney Walt Co for a number of months, seems to be bullish on the $152.85 billion market cap company. The stock rose 0.25% or $0.25 reaching $99.24. 650,713 shares of the company's stock traded hands. It has underperformed by 6.99% the S&P500. Jennison Associates LLC increased its holdings in Regeneron Pharmaceuticals by 74.1% in the 2nd quarter. (REGN) by 26.53% based on its latest 2017Q2 regulatory filing with the SEC. GOLDSTEIN JOSEPH L sold $482,550 worth of stock. The firm owned 7039884 shares of the company's stock after buying an additional 416192 shares during the period.

Regeneron Pharmaceuticals, Inc.is a biopharmaceutical firm that discovers, invents, develops, makes and commercializes medicines for the treatment of serious medical conditions. The stock declined 2.48% or $10.94 reaching $430 per share. About 347,403 shares traded. BlackRock Inc. increased its holdings in Regeneron Pharmaceuticals by 3,331.5% in the 1st quarter. It has outperformed by 0.70% the S&P500.

Investors sentiment increased to 1.38 in 2017 Q2. They expect $1.66 earnings per share, up 18.57% or $0.26 from last year's $1.4 per share. It is positive, as 42 investors sold REGN shares while 157 reduced holdings. Alpha Windward LLC raised its position in shares of Regeneron Pharmaceuticals by 11.6% in the third quarter. L S Advsr holds 0.16% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) for 1,820 shares.

Regeneron Pharmaceuticals (NASDAQ:REGN) last announced its quarterly earnings results on Friday, November 4th. First Mercantile Tru Commerce holds 0.16% or 1,800 shares. National Pension Service acquired 6,481 shares as Regeneron Pharmaceuticals (REGN)'s stock rose 21.24%. Profund Advisors Limited Liability Company reported 35,413 shares or 0.79% of all its holdings. Friess Associates Llc sold 1,554 shares as Ulta Beauty Inc. NEXT Financial Group Inc now owns 360 shares of the biopharmaceutical company's stock valued at $145,000 after buying an additional 115 shares in the last quarter. Adage Capital Prtn Gru Ltd Co holds 0.07% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) for 58,010 shares. Mitsubishi Ufj Secs Limited owns 110 shares or 0.17% of their U.S. portfolio. Livforsakringsbolaget Skandia Omsesidigt has invested 0.08% in Ulta Beauty Inc (NASDAQ:ULTA). Janus Capital Management LLC now owns 1,317,162 shares of the biopharmaceutical company's stock worth $510,406,000 after buying an additional 486,119 shares in the last quarter. Mitsubishi Ufj Trust reported 158,407 shares stake. Ameritas Inv Prtn Incorporated stated it has 0.09% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). During the same quarter previous year, the company earned $3.47 earnings per share. ULTA's profit will be $101.98M for 30.82 P/E if the $1.66 EPS becomes a reality. Sustainable Growth Advisers Lp has invested 4.42% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Since May 12, 2017, it had 1 buy, and 7 insider sales for $42.75 million activity. Sanofi bought $65.06 million worth of stock or 136,050 shares. STAHL NEIL sold $4.01M worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) on Wednesday, June 14. Regeneron Pharmaceuticals, Inc. has 8 buy ratings, 12 holds and 1 sells even after the stock tumbled -19.17% from its high of $543.55 to a $47.53 billion market value through last close.

Analysts await Regeneron Pharmaceuticals Inc (NASDAQ:REGN) to report earnings on November, 3. Clearbridge Invests Limited Liability Com reported 0.35% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Regeneron Pharmaceuticals had a net margin of 22.05% and a return on equity of 25.58%. (REGN), we can see that the 40-day commodity channel index signal is presently Hold while the 50-day Parabolic SAR generates a Sell signal. Therefore 46% are positive. J.P. Morgan maintained the stock with "Hold" rating in Monday, August 14 report. The company was maintained on Monday, September 11 by KeyBanc Capital Markets. Canaccord Genuity upgraded the shares of REGN in report on Friday, May 5 to "Buy" rating. The stock of Travelers Companies Inc (NYSE:TRV) has "Hold" rating given on Thursday, August 17 by Keefe Bruyette & Woods. The firm earned "Hold" rating on Wednesday, June 21 by Cowen & Co. Piper Jaffray maintained the shares of REGN in report on Thursday, September 7 with "Buy" rating. The firm earned "Hold" rating on Thursday, April 13 by Jefferies. Chardan Capital Markets downgraded the stock to "Sell" rating in Monday, January 25 report.

Unilever PLC (NYSE:UL) Sees Significantly Higher Trading Volume
The stock of TFS Financial Corporation (NASDAQ:TFSL) earned "Hold" rating by Keefe Bruyette & Woods on Friday, July 7. Jackson Grant Investment Advisers Inc. increased its position in Unilever PLC by 111.3% in the second quarter.

More important recent Travelers Companies Inc (NYSE:TRV) news were published by: Seekingalpha.com which released: "Travelers up 1.5% after catastrophe-affected quarter" on October 19, 2017, also Nasdaq.com published article titled: "The Travelers Companies Inc". It was reported on Oct, 20 by Barchart.com.

Analysts await Ulta Beauty Inc (NASDAQ:ULTA) to report earnings on December, 7. They expect $1.21 EPS, up 10.00% or $0.11 from last year's $1.1 per share. Sectoral Asset Mgmt invested 3.38% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Sg Americas Securities Llc decreased Wabtec Corp Com (NYSE:WAB) stake by 16,204 shares to 20,791 valued at $1.90 million in 2017Q2. It also upped Evolent Health Inc. stake by 183,163 shares and now owns 393,163 shares.

Among 37 analysts covering The Walt Disney Company (NYSE:DIS), 20 have Buy rating, 3 Sell and 14 Hold. Therefore 38% are positive. The Walt Disney Company had 129 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of USG Corporation (NYSE:USG) has "Neutral" rating given on Thursday, October 27 by Wedbush. Regeneron Pharmaceuticals has a consensus rating of "Hold" and a consensus price target of $468.87. As per Tuesday, October 20, the company rating was initiated by Pivotal Research. The rating was maintained by UBS on Thursday, September 29 with "Buy". H.C. Wainwright has "Neutral" rating and $5.0 target. The stock has "Hold" rating by Loop Capital on Wednesday, August 16.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Latest News